44
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Preparation of tofacitinib sustained-release tablets using hot melt extrusion technology

, , & ORCID Icon
Pages 248-257 | Received 22 Dec 2023, Accepted 22 Feb 2024, Published online: 04 Mar 2024

References

  • Ali SFB, Afrooz H, Hampel R, Mohamed EM, Bhattacharya R, Cook P, Khan MA, Rahman Z. 2019. Blend of cellulose ester and enteric polymers for delayed and enteric coating of core tablets of hydrophilic and hydrophobic drugs. Int J Pharm. 567:118462. doi: 10.1016/j.ijpharm.2019.118462.
  • Badawy S, Narang A, LaMarche K, Subramanian G, Varia S. 2019. Handbook of pharmaceutical wet granulation. The Netherlands: Academic Press Amsterdam.
  • Borowy CS, Ashurst JV. 2018. Physiology, zero and first order kinetics. Treasure Island (FL): StatPearls Publishing.
  • Chavan R, Thipparaboina R, Kumar D, Shastri N. 2016. Co amorphous system: a product development perspective. Int J Pharm. 515(1–2):403–415. doi: 10.1016/j.ijpharm.2016.10.043.
  • Chicco D, Warrens MJ, Jurman G. 2021. The coefficient of determination R-squared is more informative than SMAPE, MAE, MAPE, MSE and RMSE in regression analysis evaluation. PeerJ Comput Sci. 7:e623. doi: 10.7717/peerj-cs.623.
  • Collinge M, Ball DJ, Bowman CJ, Nilson AL, Radi ZA, Vogel WM. 2018. Immunologic effects of chronic administration of tofacitinib, a Janus kinase inhibitor, in cynomolgus monkeys and rats–Comparison of juvenile and adult responses. Regul Toxicol Pharmacol. 94:306–322. doi: 10.1016/j.yrtph.2018.02.006.
  • Costa P. 2001. An alternative method to the evaluation of similarity factor in dissolution testing. Int J Pharm. 220(1–2):77–83. doi: 10.1016/s0378-5173(01)00651-2.
  • Dowty ME, Lin J, Ryder TF, Wang W, Walker GS, Vaz A, Chan GL, Krishnaswami S, Prakash C. 2014. The pharmacokinetics, metabolism, and clearance mechanisms of tofacitinib, a Janus kinase inhibitor, in humans. Drug Metab Dispos. 42(4):759–773. doi: 10.1124/dmd.113.054940.
  • Gouda R, Baishya H, Qing Z. 2017. Application of mathematical models in drug release kinetics of carbidopa and levodopa ER tablets. J Dev Drugs. 06(02):1–8. doi: 10.4172/2329-6631.1000171.
  • Gupta BP, Thakur N, Jain NP, Banweer J, Jain S. 2010. Osmotically controlled drug delivery system with associated drugs. J Pharm Pharm Sci. 13(4):571–588. doi: 10.18433/j38w25.
  • Hurley D, Davis M, Walker GM, Lyons JG, Higginbotham CL. 2020. The effect of cooling on the degree of crystallinity, solid-state properties, and dissolution rate of multi-component hot-melt extruded solid dispersions. Pharmaceutics. 12(3):212. doi: 10.3390/pharmaceutics12030212.
  • Kotha R, Raghavapally SG, Adavi SL, Taranalli S, Pandey D. 2013. Current techniques in pulsatile drug delivery: a review. Int Res J Pharm. 4(3):77–84. doi: 10.7897/2230-8407.04313.
  • Kushner J IV, Lamba M, Stock T, Wang R, Nemeth MA, Alvey C, Chen R, DeMatteo V, Blanchard A. 2020. Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technology. Eur J Pharm Sci. 147:105200. doi: 10.1016/j.ejps.2019.105200.
  • Lamba M, Wang R, Fletcher T, Alvey C, Kushner J, Stock, T, 56. 2016. Extended‐release once‐daily formulation of Tofacitinib: evaluation of pharmacokinetics compared with immediate‐release Tofacitinib and impact of food. J Clin Pharmacol. 56(11):1362–1371. doi: 10.1002/jcph.734.
  • Lee HJ, Hong IK. 2009. Equilibrium partitioning of nutrient components in functional solvents. Appl Chem Eng. 20:346–350.
  • Li N, Taylor LS. 2018. Tailoring supersaturation from amorphous solid dispersions. J Control Release. 279:114–125. doi: 10.1016/j.jconrel.2018.04.014.
  • Li Y, Pan H, Duan H, Chen J, Zhu Z, Fan J, Li P, Yang X, Pan W. 2019. Double-layered osmotic pump controlled release tablets of actarit: in vitro and in vivo evaluation. Asian J Pharm Sci. 14(3):340–348. doi: 10.1016/j.ajps.2018.05.009.
  • Malaterre V, Ogorka J, Loggia N, Gurny R. 2009. Oral osmotically driven systems: 30 years of development and clinical use. Eur J Pharm Biopharm. 73(3):311–323. doi: 10.1016/j.ejpb.2009.07.002.
  • Maniruzzaman M, Nair A, Renault M, Nandi U, Scoutaris N, Farnish R, Bradley MS, Snowden MJ, Douroumis D. 2015a. Continuous twin-screw granulation for enhancing the dissolution of poorly water soluble drug. Int J Pharm. 496(1):52–62. doi: 10.1016/j.ijpharm.2015.09.025.
  • Maniruzzaman M, Pang J, Morgan DJ, Douroumis D. 2015b. Molecular modeling as a predictive tool for the development of solid dispersions. Mol Pharm. 12(4):1040–1049. doi: 10.1021/mp500510m.
  • Molina J, Laroche A, Richard J-V, Schuller A-S, Rolando C. 2019. Neural networks are promising tools for the prediction of the viscosity of unsaturated polyester resins. Front Chem. 7:375. doi: 10.3389/fchem.2019.00375.
  • Nishiwaki Y, Matsunaga T, Kumasaki M. 2019. Stabilization effects of carboxylate on pyrotechnic compositions including Mg powder in water. J Therm Anal Calorim. 137(5):1493–1498. doi: 10.1007/s10973-019-08069-z.
  • Ofokansi KC, Kenechukwu FC. 2013. Formulation development and evaluation of drug release kinetics from colon-targeted ibuprofen tablets based on Eudragit RL 100-chitosan interpolyelectrolyte complexes. Int Scholarly Res Notices. 2013:1–8. doi: 10.1155/2013/838403.
  • Oliveira G, Ferraz H, Matos J. 2005. Thermoanalytical study of glibenclamide and excipients. J Therm Anal Calorim. 79(2):267–270. doi: 10.1007/s10973-005-0047-5.
  • Owusu FW, Boakye-Gyasi ME, Mante PK, Ekuadzi E, Ofori-Kwakye K, Woode E. 2019. Formulation and evaluation of sustained release matrix tablets of capparis erythrocarpos roots extract to improve patient compliance in management of arthritis. Sci Afr. 6:e00172. doi: 10.1016/j.sciaf.2019.e00172.
  • Parikh T, Gupta SS, Meena A, Serajuddin AT. 2016. Investigation of thermal and viscoelastic properties of polymers relevant to hot melt extrusion-III: polymethacrylates and polymethacrylic acid based polymers. J Excip Food Chem. 5:1003.
  • Partheniadis I, Nikolakakis I. 2024. Development and characterization of co-amorphous griseofulvin/L-leucin by modified solvent processing hot-melt extrusion. Int J Pharm. 652:123824. doi: 10.1016/j.ijpharm.2024.123824.
  • Shoaib MH, Tazeen J, Merchant HA, Yousuf RI. 2006. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC. Pak J Pharm Sci. 19:119–124.
  • Tabriz AG, Scoutaris N, Gong Y, Hui H-W, Kumar S, Douroumis D. 2021. Investigation on Hot Melt Extrusion and Prediction on 3D Printability of Pharmaceutical Grade Polymers. Int J Pharm. 609:121187. doi: 10.1016/j.ijpharm.2021.120755.
  • Tanno FK, Sakuma S, Masaoka Y, Kataoka M, Kozaki T, Kamaguchi R, Ikeda Y, Kokubo H, Yamashita S. 2008. Site‐specific drug delivery to the middle region of the small intestine by application of enteric coating with hypromellose acetate succinate (HPMCAS). J Pharm Sci. 97(7):2665–2679. doi: 10.1002/jps.21172.
  • Thakkar R, Thakkar R, Pillai A, Ashour EA, Repka MA. 2020. Systematic screening of pharmaceutical polymers for hot melt extrusion processing: a comprehensive review. Int J Pharm. 576:118989. doi: 10.1016/j.ijpharm.2019.118989.
  • Thiry J, Krier F, Evrard B. 2015. A review of pharmaceutical extrusion: critical process parameters and scaling-up. Int J Pharm. 479(1):227–240. doi: 10.1016/j.ijpharm.2014.12.036.
  • Wu X, Zeng X, Wang L, Hang T, Song M. 2017. Identification of related substances in tofacitinib citrate by LC-MS techniques for synthetic process optimization. J Pharm Biomed Anal. 143:17–25. doi: 10.1016/j.jpba.2017.05.012.
  • Xie F, Ji S, Cheng Z. 2015. In vitro dissolution similarity factor (f2) and in vivo bioequivalence criteria, how and when do they match? Using a BCS class II drug as a simulation example. Eur J Pharm Sci. 66:163–172. doi: 10.1016/j.ejps.2014.10.002.
  • Zhao Y-N, Gu J, Jia S, Guan Y, Zhang Y. 2016. Zero-order release of polyphenolic drugs from dynamic, hydrogen-bonded LBL films. Soft Matter. 12(4):1085–1092. doi: 10.1039/c5sm02186c.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.